Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Pharmacokinetics and pharmacodynamics of oral cephalexin in children with osteoarticular infections.

Autmizguine J, Watt KM, Théorêt Y, Kassir N, Laferrière C, Parent S, Tapiéro B, Ovetchkine P.

Pediatr Infect Dis J. 2013 Dec;32(12):1340-4. doi: 10.1097/INF.0b013e3182a222a6.

PMID:
23811740
2.

[Pharmacokinetics and pharmacodynamics of antimicrobial therapy used in child osteoarticular infections].

Cohen R, Grimprel E.

Arch Pediatr. 2007 Oct;14 Suppl 2:S122-7. Review. French.

PMID:
17956820
3.

Experience with linezolid therapy in children with osteoarticular infections.

Chen CJ, Chiu CH, Lin TY, Lee ZL, Yang WE, Huang YC.

Pediatr Infect Dis J. 2007 Nov;26(11):985-8.

PMID:
17984803
4.
5.

[Pharmacokinetics of vancomycin in children hospitalized in a critical care unit].

Acuña C, Morales J, Castillo C, Torres JP.

Rev Chilena Infectol. 2013 Dec;30(6):585-90. doi: 10.4067/S0716-10182013000600001. Spanish.

6.

Acute bacterial osteoarticular infections: eight-year analysis of C-reactive protein for oral step-down therapy.

Arnold JC, Cannavino CR, Ross MK, Westley B, Miller TC, Riffenburgh RH, Bradley J.

Pediatrics. 2012 Oct;130(4):e821-8. doi: 10.1542/peds.2012-0220. Epub 2012 Sep 10.

PMID:
22966033
7.

Epidemiology of acute osteoarticular sepsis in a setting with a high prevalence of pediatric HIV infection.

Robertson AJ, Firth GB, Truda C, Ramdass DA, Groome M, Madhi S.

J Pediatr Orthop. 2012 Mar;32(2):215-9. doi: 10.1097/BPO.0b013e3182468cd7.

PMID:
22327459
8.

Exploration of optimal dosing regimens of vancomycin in patients infected with methicillin-resistant Staphylococcus aureus by modeling and simulation.

Lim HS, Chong YP, Noh YH, Jung JA, Kim YS.

J Clin Pharm Ther. 2014 Apr;39(2):196-203. doi: 10.1111/jcpt.12123. Epub 2014 Jan 16.

PMID:
24428720
9.

Pharmacokinetics and tissue fluid distribution of cephalexin in the horse after oral and i.v. administration.

Davis JL, Salmon JH, Papich MG.

J Vet Pharmacol Ther. 2005 Oct;28(5):425-31.

PMID:
16207304
10.

Population pharmacokinetic and pharmacodynamic modeling of high-dose intermittent ticarcillin-clavulanate administration in pediatric cystic fibrosis patients.

Zobell JT, Stockmann C, Young DC, Cash J, McDowell BJ, Korgenski K, Sherwin CM, Spigarelli M, Chatfield BA, Ampofo K.

Clin Ther. 2011 Nov;33(11):1844-50. doi: 10.1016/j.clinthera.2011.09.010. Epub 2011 Oct 21.

PMID:
22018680
11.

Chronopharmacological study of cephalexin in dogs.

Prados AP, Ambros L, Montoya L, Rebuelto M.

Chronobiol Int. 2007;24(1):161-70.

PMID:
17364586
12.

Management of osteoarticular infections caused by Staphylococcus aureus is similar to that of other etiologies: analysis of 199 staphylococcal bone and joint infections.

Pääkkönen M, Kallio PE, Kallio MJ, Peltola H.

Pediatr Infect Dis J. 2012 May;31(5):436-8. doi: 10.1097/INF.0b013e31824657dd.

PMID:
22189524
13.
14.

[Study of pharmacokinetics/pharmacodynamics of levofloxacin].

Zhang J, Yu JC, Shi YG, Zhou L, Ye XY, Zhu DM, Zhang YY.

Zhonghua Yi Xue Za Zhi. 2005 Jul 20;85(27):1926-32. Chinese.

PMID:
16255991
16.

Acute hematogenous osteomyelitis and septic arthritis in children: clinical characteristics and outcomes study.

Sukswai P, Kovitvanitcha D, Thumkunanon V, Chotpitayasunondh T, Sangtawesin V, Jeerathanyasakun Y.

J Med Assoc Thai. 2011 Aug;94 Suppl 3:S209-16.

PMID:
22043778
17.

Vancomycin dosing assessment in intensive care unit patients based on a population pharmacokinetic/pharmacodynamic simulation.

Revilla N, Martín-Suárez A, Pérez MP, González FM, Fernández de Gatta Mdel M.

Br J Clin Pharmacol. 2010 Aug;70(2):201-12. doi: 10.1111/j.1365-2125.2010.03679.x.

18.

Use of preclinical data for selection of a phase II/III dose for evernimicin and identification of a preclinical MIC breakpoint.

Drusano GL, Preston SL, Hardalo C, Hare R, Banfield C, Andes D, Vesga O, Craig WA.

Antimicrob Agents Chemother. 2001 Jan;45(1):13-22.

19.

Changing patterns of acute hematogenous osteomyelitis and septic arthritis: emergence of community-associated methicillin-resistant Staphylococcus aureus.

Arnold SR, Elias D, Buckingham SC, Thomas ED, Novais E, Arkader A, Howard C.

J Pediatr Orthop. 2006 Nov-Dec;26(6):703-8.

PMID:
17065930
20.

Prospective monitoring of cefepime in intensive care unit adult patients.

Chapuis TM, Giannoni E, Majcherczyk PA, Chioléro R, Schaller MD, Berger MM, Bolay S, Décosterd LA, Bugnon D, Moreillon P.

Crit Care. 2010;14(2):R51. doi: 10.1186/cc8941. Epub 2010 Apr 1.

Supplemental Content

Support Center